findmyKOL

Matthew Weir, MD

Enriched profile

Professor of Medicine; Division Head, Nephrology at University of Maryland School of Medicine · University of Maryland School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyNephrologyFocusRenal Transplantation Outcomes and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2007–2026

Matthew Weir is Professor of Medicine; Division Head, Nephrology at University of Maryland School of Medicine at University of Maryland School of Medicine. OpenAlex indexes 584 publications with 25,906 citations (h-index 85); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.

Data verified 13 Oct 2026

Overview

Updated 14 Oct 2026

Matthew Weir, M.D., is Professor of Medicine at University of Maryland School of Medicine. The public record shows 584 publications with 25,906 citations (h-index 85), centered on Renal Transplantation Outcomes and Treatments, Chronic Kidney Disease and Diabetes, Transplantation: Methods and Outcomes. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 42 companies, 3 NIH-funded awards (2007–2026).

  • Most recent indexed publication: 2026 · Clinical journal of the American Society of Nephrology
  • Top research focus: Renal Transplantation Outcomes and Treatments
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 42 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Chronic Kidney Disease1 trialAcute Kidney Injury1 trialHypertensionESRD / Dialysis

Research focus

OpenAlex concept fingerprint
Renal Transplantation Outcomes and TreatmentsChronic Kidney Disease and DiabetesTransplantation: Methods and OutcomesBlood Pressure and Hypertension StudiesDialysis and Renal Disease Management

Drugs & molecules

across trials, industry payments and publications
Kerendiageneric · FinerenoneClinical trials—Industry payments65Publications3Veltassageneric · PatiromerClinical trials—Industry payments16Publications4Jardiancegeneric · EmpagliflozinClinical trials—Industry payments3Publications3Korlymgeneric · MifepristoneClinical trials—Industry payments23Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments13Publications—Lokelmageneric · Sodium zirconium cyclosilicateClinical trials—Industry payments11Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments10Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments9Publications—Nexlizetgeneric · Bempedoic acid / ezetimibeClinical trials—Industry payments6Publications—Krystexxageneric · PegloticaseClinical trials—Industry payments5Publications—Auryxiageneric · Ferric citrateClinical trials—Industry payments3Publications—Korsuvageneric · DifelikefalinClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments70Novo Nordisk IncClinical trials—Industry payments51Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments30Corcept TherapeuticsClinical trials—Industry payments23Janssen Pharmaceuticals, IncClinical trials—Industry payments22Vifor Pharma, Inc.Clinical trials—Industry payments18AstraZeneca Pharmaceuticals LPClinical trials—Industry payments16Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments10Esperion Therapeutics, Inc.Clinical trials—Industry payments9AstraZeneca UK LimitedClinical trials—Industry payments7Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments6Novartis Pharmaceuticals CorporationClinical trials—Industry payments6Vifor (International) Ltd.Clinical trials—Industry payments6Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments5Horizon Therapeutics plcClinical trials—Industry payments5Akebia Therapeutics IncClinical trials—Industry payments4GlaxoSmithKline, LLC.Clinical trials—Industry payments4Lexicon Pharmaceuticals, Inc.Clinical trials—Industry payments4Eli Lilly and CompanyClinical trials—Industry payments3Janssen Scientific Affairs, LLCClinical trials—Industry payments3Lilly USA, LLCClinical trials—Industry payments3Merck Sharp & Dohme LLCClinical trials—Industry payments3Seqirus USA IncClinical trials—Industry payments3Amgen Inc.Clinical trials—Industry payments2Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments2Idorsia Pharmaceuticals Us IncClinical trials—Industry payments2Travere Therapeutics, Inc.Clinical trials—Industry payments2Ardelyx, Inc.Clinical trials—Industry payments1Boa Biomedical, Inc.Clinical trials1Industry payments—Calliditas Therapeutics Us Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
584publications

Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.

25,906citations

Total citations across indexed works.

85h-index

Hirsch index (OpenAlex). i10-index 284.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
42companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2007–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

42 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    71.8%
    Calcium channel blocker16%
    Amlodipine Besylate81%Nifedipine Er19%
    Part D<11 patients
    alpha-Adrenergic Blocker10.3%
    Doxazosin Mesylate100%
    Part D≥25 patients

    + 10 more classes in this area

  • Metabolism & gastrointestinal

    9.4%
    Corticosteroid5.6%
    Prednisone100%
    Part D≥11 patients
    Proton pump inhibitor2.7%
    Pantoprazole Sodium61%Esomeprazole Magnesium39%
    Part D<11 patients

    + 1 more class in this area

  • Hormonal (systemic)

    5.5%
    Calcium-sensing Receptor Agonist5.5%
    Cinacalcet Hcl100%
    Part D≥13 patients
All 8 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)20.6% facility · 79.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

3 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:

Congress activity

Updated 14 Oct 2026

6 congress contributions (2017–2025) across ADA, AMCP, ENDO per OpenAlex. The most recent:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jeffrey Craig Fink67David K. Klassen62Stephen T. Bartlett57George L. Bakris42Charles B. Cangro35John C. Papadimitriou33Cinthia Beskow Drachenberg32Eugene J. Schweitzer30Bertram Pitt27Jiang He25Chi‐yuan Hsu24James Phillip Lash24Harold I. Feldman22Lawrence J. Appel22Ann Wiland22Raymond R. Townsend21Mahboob Rahman20Abdolreza Haririan20Jonathan S. Bromberg19Alan S. Go18Dahlia Garza17Martha R. Mayo17John W. Kusek16MATTHEW M. COOPER15David A. Bushinsky15Lance Berman14Ana Catherine Ricardo14Emilio Ramos13Michael R. Lattanzio13Panduranga S. Rao13Jing Chen13B.L. Kasiske13Cinthia Drachenberg12Edward J. Horwitz12Amanda Hyre Anderson12Ravinder K. Wali12Joseph M. Nogueira12Stefan D. Anker11Mark L. Unruh11Benjamin Philosophe11

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Other

    medschool.umaryland.edu/profiles/weir-matthew

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certification

    American Board of Internal Medicine - Nephrology

    1984
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗
  • Board Certification

    American Board of Internal Medicine - Internal Medicine

    1981
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗
  • M.D.

    University of Virginia

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
  • B.A.

    University of Virginia

    1974
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗

Editorial & leadership roles

journal and society appointments
  • Director

    Division of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗
  • Section Editor

    Current Hypertension Reports

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
  • Section Editor

    Current Opinion in Hypertension and Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
  • Associate Editor

    Clinical Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
  • Associate Editor

    American Journal of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
  • Editorial Board Member

    Medscape Nephrology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wp.medscape.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Member

    American Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗
  • Member

    National Kidney Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗
  • Member

    American Heart Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗
  • Member

    American Society of Transplantation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umms.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.